Switching among biologic therapies is common practice in patients with rheumatoid arthritis who have an inadequate response or intolerable adverse events. Evidence from observational studies and ...

Tolerability challenges have been identified with tumor necrosis factor (TNF) antagonist therapy in the treatment of rheumatoid arthritis ... including both non-biologic DMARDs such as MTX ...

Identify triggers, recognize symptoms, and manage RA flare-ups effectively with lifestyle, medication, and support for better ...

Medically reviewed by Stella Bard, MD Osteoarthritis (OA) and rheumatoid arthritis (RA) are two of the most common types of ...

Rheumatoid Arthritis Awareness Day 2025 is observed on February 2. Created in 2013 by the Rheumatoid Patient Foundation, it is to raise awareness around the chronic autoimmune disease. Rheumatoid ...

autoantibodies against citrullinated IGF2BP1 are detected in patients with rheumatoid arthritis and positively correlate with disease severity.

“Asthma and rheumatoid arthritis (RA) are both prevalent diseases ... oral corticosteroids, biologics and azathioprine. Ramonell and Wenzel called these findings that eight of nine patients ...

Five out of every 1,000 Malaysians are affected by Rheumatoid Arthritis (RA), a condition that causes chronic autoimmune ...

The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global ...

A link between rheumatoid arthritis and appendicitis has been investigated before, but newer research has not confirmed these findings. Rheumatoid arthritis is an autoimmune disease where the ...